{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:53Z","timestamp":1789977353003,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001203","name":"GlaxoSmithKline Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jpeds.2019.07.057","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:54:07Z","timestamp":1569344047000},"page":"252-253.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe"],"prefix":"10.1016","volume":"213","author":[{"given":"Corinne","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Ouldali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Caeymaex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Angoulvant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2019.07.057_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study","volume":"5","author":"Savulescu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jpeds.2019.07.057_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3201\/eid2403.170769","article-title":"Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel","volume":"24","author":"Rokney","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","article-title":"Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey","volume":"18","author":"Ouldali","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib5","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/INF.0000000000001862","article-title":"Antibiotic resistance of potential otopathogens isolated from nasopharyngeal flora of children with acute otitis media before, during and after pneumococcal conjugate vaccines implementation","volume":"37","author":"Rybak","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2019.07.057_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21645515.2015.1095414","article-title":"Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel","volume":"12","author":"Ben-Shimol","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.jpeds.2019.07.057_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz178","article-title":"Persistent circulation of vaccine serotypes and serotype replacement after five years of UK infant immunisation with PCV13","author":"Kandasamy","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib8","series-title":"Invasive pneumococcal disease - annual epidemiological report for 2017","year":"2017"},{"key":"10.1016\/j.jpeds.2019.07.057_bib9","article-title":"Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation","author":"Levy","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(18)30346-3","article-title":"Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?","volume":"18","author":"Desmet","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib11","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2017.11.085","article-title":"Invasive pneumococcal disease in children under 16\u202fyears of age: incomplete rebound in incidence after the maximum effect of PCV13 in 2012\/13 in Germany","volume":"36","author":"Weinberger","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2019.07.057_bib13","doi-asserted-by":"crossref","first-page":"e0210278","DOI":"10.1371\/journal.pone.0210278","article-title":"Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany","volume":"14","author":"Perniciaro","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2019.07.057_bib14","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2018.03.001","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland","volume":"36","author":"Rinta-Kokko","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2019.07.057_bib15","article-title":"Resurgence of pneumococcal meningitis in Europe and Northern America","author":"Koelman","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2019.07.057_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jamapediatrics.2018.5273","article-title":"Long-term association of 13-valent pneumococcal conjugate vaccine implementation with rates of community-acquired pneumonia in children","volume":"173","author":"Ouldali","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2019.07.057_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12916-018-1004-z","article-title":"Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control","volume":"16","author":"Thorrington","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jpeds.2019.07.057_bib18","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2019.07.057_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz142","article-title":"Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: a birth-cohort based study","author":"Wiese","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib20","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2019.01.064","article-title":"Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study","volume":"37","author":"Fortanier","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2019.07.057_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz281","article-title":"Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment","author":"Ouldali","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpeds.2019.07.057_bib22","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis","volume":"77","author":"Balsells","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jpeds.2019.07.057_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jpeds.2019.07.057_bib25","series-title":"Paper presented at the 37th Annual Meeting\u00a0of the European Society for Paediatric Infectious Diseases, Abstract N\u00b0 ESPID19-0162. May 6-11","article-title":"A phase 2, double-blind, randomized, multicenter trial to evaluate the safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (pcv15) compared to pcv13 in healthy infants","author":"Hurtado","year":"2019"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619309655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347619309655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:03:51Z","timestamp":1758359031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347619309655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":25,"alternative-id":["S0022347619309655"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.07.057","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2019.07.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}